Evidence map›Paper›PMID 40997285›Full record

ArticleNeurology2025

Role of the Proportional Odds Assumption for the Analysis of Ordinal Outcomes in Neurologic Trials.

Yongxi Long, Eveline J A Wiegers, Bart C Jacobs, Ewout W Steyerberg, Erik W van Zwet

Abstract read
In one paragraph

Article in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yongxi LongBiomedical Data Sciences, Leiden University Medical Center, the Netherlands.ORCID 0009-0002-8871-152X
Eveline J A WiegersDepartment of Neurology, Erasmus MC, Rotterdam, the Netherlands.ORCID 0000-0003-3219-210X
Bart C JacobsDepartment of Neurology, Department of Immunology, Erasmus MC, Rotterdam, the Netherlands; and.ORCID 0000-0002-8985-2458
Ewout W SteyerbergJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands.ORCID 0000-0002-7787-0122
Erik W van ZwetBiomedical Data Sciences, Leiden University Medical Center, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ordinal scales are categories ordered by their clinical preference, such as the modified Rankin Scale and Glasgow Outcome Scale Extended. They are widely used as key outcome measures in neurologic trials. Compared with binary outcomes, ordinal scales allow a more detailed assessment of the effect of the treatment and provide more statistical power. Typically, the proportional odds (PO) model (or "shift analysis") is used to quantify the treatment effect in a common odds ratio (cOR) and to test the null hypothesis that the treatment has no effect. Clinical researchers and trialists may worry that the PO assumption will not hold and therefore decide to dichotomize the ordinal scale into a binary outcome. Here, we explain that for the purpose of testing the presence of a treatment effect, it is irrelevant whether the PO assumption holds. In fact, pretesting this assumption to decide which test to use for the treatment effect is invalid and can inflate the type I error probability. Although the PO assumption is not relevant for testing, it is definitely relevant for the purpose of describing and summarizing the treatment effect. We suggest a simple graphical check of the PO assumption as more informative than formal testing. If we are satisfied that there is no substantial violation of the PO assumption, it is reasonable to summarize the treatment effect into a single number such as the cOR. Otherwise, no single-number summary measure provides a faithful representation. We illustrate these practical considerations with 3 neurologic trials: the Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients with a Large Infarct Core (ANGEL-ASPECT) trial and the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands ([MR CLEAN], which investigated endovascular therapy in stroke) and the RESCUEicp trial (which investigated decompressive craniectomy in traumatic brain injury). We conclude with recommendations for the statistical workflow. Undue concerns about the PO assumption should not deter researchers from using ordinal scales in neurologic trials. We provide an R package

Indexed as

Clinical Trials as TopicModels, StatisticalOutcome Assessment, Health CareHumansTreatment Outcome

Identifiers

PMID40997285
PMCPMC12473177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.